This month’s discussion was led by Pieter van der Velden. Topics included improving multiplex assays, T-Cell quantification and DNA methylation.

Single-cell proteomics has developed quickly, despite being a relatively new field. NanoPOTS and FACS are being used to improve proteome coverage and minimise sample size.

At NGO US: In-Person 2022, Carlos Cruchaga of the Washington School of Medicine presents on using QTL and GWAS data to unlock the future of therapeutic treatment for neurodegenerative disease.

Explore the history of PCR and how digital droplet PCR is being used to further understanding of Sars-Cov2 severity.

With the development of single-cell RNA sequencing, it became possible to measure transcriptomes at a single-cell resolution. Is spatial transcriptomics the next step on the journey of understanding human biology?

Presented by Oliver Braubach, Ph.D.Head of Applications at Akoya Biosciences Inc.

In this video interview, Rea Dabelic tells us more about how 10x Genomics’ tools were used to gain a deeper understanding of COVID-19 and the immune system's response to viruses and vaccines over the course of the pandemic. Watch and learn more about how single-cell and spatial multi-omics can be leveraged to transform the way we approach and treat today’s pathogenic threats.

Our February discussion group bought together more than 40 key opinion leaders to debate the future of spatial biology. Spatial transcriptomics, single cell resolution and tissue preparation were among the key topics raised.

We sat down with the Co-director of Yale Genome Editing Centre of Yale University, Xiaojun Xing, to discuss his breakthrough cryopreservation method and his thoughts on the genome editing landscape.

Our February Omics discussion group focused on novel genome editing and how new technologies are being used to tackle the challenges of transitioning to therapeutic use.